Moors & Cabot, Inc.
- SEC CIK
- 0001607239
- Latest filing
- Aug 10, 2026
NVS holding history
Novartis AG in every 13F filed by Moors & Cabot, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVS overviewAll 13F holders of NVSFull Q2 2026 holdings
- Shares (Q2 2026)
- 28,770
- Value
- $4.51M
- % of portfolio
- 0.2%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 28,770 | $4.51M | 0.2% | −1,211−4.0% | Reduced | Holders |
| Q1 2026 | 29,981 | $4.58M | 0.2% | +369+1.2% | Added | Holders |
| Q4 2025 | 29,612 | $4.08M | 0.2% | +320+1.1% | Added | Holders |
| Q3 2025 | 29,292 | $3.76M | 0.2% | −1,770−5.7% | Reduced | Holders |
| Q2 2025 | 31,062 | $3.76M | 0.2% | +1,815+6.2% | Added | Holders |
| Q1 2025 | 29,247 | $3.26M | 0.2% | +1,382+5.0% | Added | Holders |
| Q4 2024 | 27,865 | $2.71M | 0.1% | −694−2.4% | Reduced | Holders |
| Q3 2024 | 28,559 | $3.28M | 0.2% | −250−0.9% | Reduced | Holders |
| Q2 2024 | 28,809 | $3.07M | 0.2% | −183−0.6% | Reduced | Holders |
| Q1 2024 | 28,992 | $2.80M | 0.2% | −550−1.9% | Reduced | Holders |
| Q4 2023 | 29,542 | $2.98M | 0.2% | +250+0.9% | Added | Holders |
| Q3 2023 | 29,292 | $2.98M | 0.2% | +250+0.9% | Added | Holders |
| Q2 2023 | 29,042 | $2.93M | 0.2% | −1,005−3.3% | Reduced | Holders |
| Q1 2023 | 30,047 | $2.76M | 0.2% | +265+0.9% | Added | Holders |
| Q4 2022 | 29,782 | $2.70M | 0.2% | −1,138−3.7% | Reduced | Holders |
| Q3 2022 | 30,920 | $2.35M | 0.2% | −297−1.0% | Reduced | Holders |
| Q2 2022 | 31,217 | $2.64M | 0.2% | +252+0.8% | Added | Holders |
| Q1 2022 | 30,965 | $2.72M | 0.2% | +563+1.9% | Added | Holders |
| Q4 2021 | 30,402 | $2.66M | 0.2% | −31,598−51.0% | Reduced | Holders |
| Q3 2021 | 62,000 | $5.05M | 0.3% | +31,683+104.5% | Added | Holders |
| Q2 2021 | 30,317 | $2.77M | 0.2% | +462+1.5% | Added | Holders |
| Q1 2021 | 29,855 | $2.55M | 0.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.